Antiepileptics May Get Class Suicide Warning Though Classwide Risk Was Not Seen
This article was originally published in The Pink Sheet Daily
Executive Summary
Three of the 11 drugs studied did not exhibit a strong suicidality signal, but FDA says the data merit a “black box” warning for all.